Eutropics is partnering with pharmaceutical companies and academic hospitals to utilize PraediCare Dx™-based assays as companion diagnostic tests for new and repurposed drugs. Biomarker tests are validated and used to expedite approval and guide use of NDEs.

The process of utilizing the Praedicare Dx™ assays for particular therapies involves performing test and training sets to establish a correlation with response followed by verification in larger clinical studies. Eutropics adds value to the drug development process and to post-marketing studies by providing a powerful metric to identify those patients who may most benefit from treatments.